Differential-effects of tumor promoters and cytokines on protooncogene expression in a hematopoietic cytokine-dependent cell-line

Autor: Pa Algate, Kd Prevost, G Arana, Mw Mayo, Xy Wang, Mk White, Ja Mccubrey, Ls Steelman

Publikováno v: Oncology reports. 1(2)

In order to investigate the mechanisms by which cytokines and tumor promoters stimulate cell growth, the expression of genes implicated in the regulation of cellular proliferation were examined in an interleukin-3 (IL-3) dependent hematopoietic cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5317fd357388ed7eb3cd77127c7d0759
https://pubmed.ncbi.nlm.nih.gov/21607354

Differential-effects of viral and cellular oncogenes on the growth factor-dependency of hematopoietic-cells

Autor: D Mylott, Ls Steelman, Ew Davidian, Xy Wang, Mk White, P Robbins, Pa Algate, C White, Pe Hoyle, Ja Mccubrey, Kd Prevost

Publikováno v: International journal of oncology. 7(2)

The effects of different viral and cellular oncogenes on the cytokine-dependency of murine hematopoietic cell lines were compared. The myeloid FDC-P1 cell line was sensitive to abrogation of growth factor-dependency by the constitutive expression of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dedc2b74f33f66cb1b3baeea82fe7181
https://pubmed.ncbi.nlm.nih.gov/21552839

MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Autor: Hernandez-Hoyos G; Emergent BioSolutions, Seattle, Washington., Sewell T; Emergent BioSolutions, Seattle, Washington., Bader R; Emergent BioSolutions, Seattle, Washington., Bannink J; Emergent BioSolutions, Seattle, Washington., Chenault RA; Emergent BioSolutions, Seattle, Washington., Daugherty M; Emergent BioSolutions, Seattle, Washington., Dasovich M; Emergent BioSolutions, Seattle, Washington., Fang H; Emergent BioSolutions, Seattle, Washington., Gottschalk R; Emergent BioSolutions, Seattle, Washington., Kumer J; Emergent BioSolutions, Seattle, Washington., Miller RE; Emergent BioSolutions, Seattle, Washington., Ravikumar P; Emergent BioSolutions, Seattle, Washington., Wiens J; Emergent BioSolutions, Seattle, Washington., Algate PA; Emergent BioSolutions, Seattle, Washington., Bienvenue D; Emergent BioSolutions, Seattle, Washington., McMahan CJ; Emergent BioSolutions, Seattle, Washington., Natarajan SK; Emergent BioSolutions, Seattle, Washington., Gross JA; Emergent BioSolutions, Seattle, Washington., Blankenship JW; Emergent BioSolutions, Seattle, Washington. jblankenship@ebsi.com.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2016 Sep; Vol. 15 (9), pp. 2155-65. Date of Electronic Publication: 2016 Jul 12.

Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform, SHIPdelta.

Autor: Wolf I; Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, Washington, 98109-1024, USA., Lucas DM, Algate PA, Rohrschneider LR

Publikováno v: Genomics [Genomics] 2000 Oct 01; Vol. 69 (1), pp. 104-12.

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs.

Autor: Blalock WL; Department of Microbiology and Immunology, East Carolina University School of Medicine Greenville, NC 27858, USA., Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA

Publikováno v: Leukemia [Leukemia] 1999 Aug; Vol. 13 (8), pp. 1109-66.